Back to results
CompletedPhase 2

Ambroxol as a Disease-modifying Treatment in GBA-PD

NCT05287503

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

+2 additional locations

View on ClinicalTrials.gov
Ambroxol as a Disease-modifying Treatment in GBA-PD — TrialFind